News
-
-
-
-
PRESS RELEASE
2025 Annual Results: Strong sales growth, expansion of the customer portfolio and BioSolutions, and strengthening of the financial structure thanks to Huvepharma
Fermentalg reports a record 2025 turnover of €13.4 million, stable operating profit, post-closing loan from Huvepharma, promising outlook with new product launches, and a target of €20 million revenue by 2026 -
-
-
PRESS RELEASE
EFSA's favorable opinion on Fermentalg's Galdieria Blue colorant paves the way for its commercialization in Europe
EFSA approves Fermentalg's natural blue colorant, opening doors for European market. Regulatory approvals signify progress towards global deployment in food and health sectors -
-
-